The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...

Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

A group of mothers in Victoria say they've experienced trouble accessing the jab for a highly infectious illness that infects ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

Discover how Professor Shabir Madhi is advancing maternal vaccines to safeguard newborns from RSV, GBS, and more.

While respiratory syncytial virus (RSV) typically causes mild symptoms in adults, the virus can be life-threatening for infants. The seasonal virus is the most common cause of lower respiratory tract ...

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.

Colds and flu often cause sore throats that make swallowing and talking uncomfortable, while RSV in adults and older children usually mimics a mild cold. Cepacol® explores why sore throats are more ...

Medical staff in Western Australia have been warned after reports of the wrong immunisations being given to patients.

In this article, we identify the top 10 most impactful articles for pediatric hospital medicine in 2025, as presented at the ...

The recommendation for Enflonsia is indicated for respiratory syncytial virus prevention in infants under eight months of age, expanding protection options ahead of the 2025–2026 season.